Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:13 AM
Ignite Modification Date: 2025-12-26 @ 12:42 AM
NCT ID: NCT02253160
Description: None
Frequency Threshold: 0
Time Frame: AEs were captured per protocol from the first dose of G-CSF until final follow up, which was typically 1 day after the last CMNC Collection Procedure for a total of 7 days.
Study: NCT02253160
Study Brief: An Evaluation of the Spectra Optia CMNC Collection Procedure
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Pre-collection Subjects screened and received G-CSF. None None 0 23 22 23 View
Spectra Optia Subject who received Spectra Optia CMNC collection procedure. None None 0 23 13 23 View
COBE Spectra Subjects who received COBE Spectra MNC collection procedure. None None 0 22 16 22 View
Follow up Subjects who completed cross-over design and were followed for at least 1 day. None None 0 23 2 23 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
platelet count decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA (17.1) View
back pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (17.1) View
bone pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (17.1) View
paraesthesia SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
palpitations SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (17.1) View
hypoaesthesia oral SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
abdominal distension SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
abdominal pain lower SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (17.1) View
infusion site extravasation SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.1) View
injection site pain SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.1) View
decreased appetite SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA (17.1) View
muscle spasm SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (17.1) View
arthralgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (17.1) View
musculoskeletal pain SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA (17.1) View
musculoskeletal stiffness SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (17.1) View
pain in extremity SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (17.1) View
headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
neuropathy peripheral SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
peripheral sensory neuropathy SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
tension headach SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (17.1) View
insomina SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (17.1) View
restlessness SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (17.1) View
thrombocytopenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA (17.1) View
fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA (17.1) View
hemoglobin decreased SYSTEMATIC_ASSESSMENT Investigations MedDRA (17.1) View